EHC on NYSE

Encompass Health

Logo: encompasshealth.com5

American health care company

Encompass Health Corporation, formerly Amcare and HealthSouth, based in Birmingham, Alabama, is the United States's largest provider of inpatient rehabilitative services, offering facility-based care through its network of 173 inpatient rehabilitation hospitals located in 39 states and Puerto Rico.3 It was founded by Richard M. Scrushy.1 Its shares trade on NYSE under the symbol EHC.1 Wikipedia text CC BY-SA 4.0

Price unavailable

Last updated Oct 21, 2026.

Overview

1984Founded1

Compare with Select Medical, Magellan Health or Pediatrix Medical Group, or pick any stock.

  • TickerEHC on NYSE1
  • Industryhealth care1
  • HeadquartersBirmingham1
  • Websitewww.encompasshealth.com
  • Legal formDelaware corporation1
  • Incorporated inDE6
  • Business address9001 Liberty Parkway, Birmingham, Al 352426
  • Filer categoryLarge accelerated filer6
  • LEI549300FVRPM9DRQZRG644
  • StatusActive4
  • LEI statusLapsed (not renewed)4
  • Registered addressC/O THE CORPORATION TRUST COMPANY, 19808 Wilmington, United States4
  • Registered withDivision of Corporations, Department of State, 20289174

Encompass Health Corporation, formerly Amcare and HealthSouth, based in Birmingham, Alabama, is the United States's largest provider of inpatient rehabilitative services, offering facility-based care through its network of 173 inpatient rehabilitation hospitals located in 39 states and Puerto Rico. Encompass Health's hospitals focus on providing rehabilitative treatment and care to patients who are recovering from stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions and amputations. The company operated a home health and hospice business that was spun off as Enhabit in 2022.3

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

9.5%Net margin9
10.5%Revenue growth, 20259
23.2%Return on equity9

What sells

Revenue by product, business segment and region, as the company reports it to the SEC.

Products and services

Inpatient brought in 97% of the revenue Encompass Health broke down this way in fiscal 2025.

  1. Inpatient$5.8B997%up 10% from 2024
  2. Other$178.9M93%up 25% from 2024
Products and services by year
Products and services202320242025
Inpatient$4.7B$5.2B$5.8B
Other$107.4M$142.7M$178.9M

Where the money goes

Where each dollar of revenue went, fiscal 2025

  • Other costs87¢$5.2B
  • Income tax3¢$192.9M
  • Profit10¢$566.2M

Out of $5.9B in revenue.9

Financial statements

Revenue101112139$5.9B in 2025+29% since 2019
0$2.0B$4.0B$6.0B2019: $4.6B$4.6B20192020: $3.6B$3.6B2020−23%2021: $4.0B$4.0B2021+13%2022: $4.3B$4.3B2022+8%2023: $4.8B$4.8B2023+10%2024: $5.4B$5.4B2024+12%2025: $5.9B$5.9B2025+10%
Operating income1411$539.5M in 2022−12% since 2019
0$200.0M$400.0M$600.0M$800.0M2019: $612.1M$612.1M20192020: $563.9M$563.9M2020−8%2021: $559.6M$559.6M2021−1%2022: $539.5M$539.5M2022−4%
Net income101112139$566.2M in 2025+58% since 2019
0$200.0M$400.0M$600.0M2019: $358.7M$358.7M20192020: $284.2M$284.2M2020−21%2021: $412.2M$412.2M2021+45%2022: $271.0M$271.0M2022−34%2023: $352.0M$352.0M2023+30%2024: $455.7M$455.7M2024+29%2025: $566.2M$566.2M2025+24%

Every line of the income statement as filed: the last 3 fiscal years, latest first.9

Period ending2025-12-312024-12-312023-12-31
Net operating revenues$5.9B$5.4B$4.8B
Salaries and benefits$3.1B$2.9B$2.6B
Other operating expenses$888.7M$802.6M$719.1M
Occupancy costs$59.0M$57.3M$56.3M
Supplies$254.4M$239.0M$218.3M
General and administrative expenses$236.2M$209.2M$201.7M
Depreciation and amortization$327.9M$299.6M$273.9M
Total operating expenses$4.9B$4.5B$4.1B
Loss on early extinguishment of debt$0$600.0K$0
Interest expense and amortization of debt discounts and fees$123.2M$137.4M$143.5M
Other income-$18.8M-$20.1M-$15.7M
Equity in net income of nonconsolidated affiliates-$4.3M-$3.0M-$3.2M
Income from continuing operations before income tax expense$953.0M$749.6M$607.2M
Provision for income tax expense$192.9M$150.2M$132.2M
Income from continuing operations$760.1M$599.4M$475.0M
Loss from discontinued operations, net of tax-$1.0M-$2.8M-$12.0M
Net income$759.1M$596.6M$463.0M
Less: Net income attributable to noncontrolling interests-$192.9M-$140.9M-$111.0M
Net income attributable to Encompass Health$566.2M$455.7M$352.0M
Basic (in shares)100.5M shares99.9M shares99.5M shares
Diluted (in shares)102.2M shares102.2M shares101.3M shares
Continuing operations (in dollars per share)$6$5$4
Discontinued operations (in dollars per share)-$0-$0-$0
Net income (in dollars per share)$5.62$4.53$3.51
Continuing operations (in dollars per share)$6$4$4
Discontinued operations (in dollars per share)-$0-$0-$0
Net income (in dollars per share)$5.54$4.46$3.47
Income from continuing operations$567.2M$458.5M$364.0M
Loss from discontinued operations, net of tax-$1.0M-$2.8M-$12.0M

Compare Encompass Health with another company

Corporate structure

Encompass Health sits at the top of its group. 3 entities, 2 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of Encompass Health

  • Encompass Health Birmingham, Alabama, United States
    • HCS Limited Subsidiary · Cayman Islands
    • HealthSouth Rehabilitation Hospital of Tinton Falls Subsidiary · Tinton Falls, United States

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; subsidiaries, stakes and holdings from Wikidata (CC0); major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What Encompass Health reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Finance-lease assets$195.9M9 Dec 31, 2025$221.5M9 Dec 31, 2024−11.6%
Operating-lease assets (leased space)$212.6M9 Dec 31, 2025$203.7M9 Dec 31, 2024+4.4%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$72.2M9 Dec 31, 2025$85.4M9 Dec 31, 2024−15.5%

Intangibles and goodwill

ItemLatestA year beforeChange
Goodwill$1.3B9 Dec 31, 2025$1.3B9 Dec 31, 2024+2.6%
Intangible assets, net (excluding goodwill)$308.3M9 Dec 31, 2025$297.8M9 Dec 31, 2024+3.5%
Finite-lived intangibles, gross$700.5M9 Dec 31, 2025$666.0M9 Dec 31, 2024+5.2%
Accumulated amortization$392.2M9 Dec 31, 2025$368.2M9 Dec 31, 2024+6.5%
Finite-lived intangibles, net$308.3M9 Dec 31, 2025$297.8M9 Dec 31, 2024+3.5%

Properties, in its own words

We currently maintain our principal executive office at 9001 Liberty Parkway, Birmingham, Alabama, the lease for which expires in 2033 and has multiple renewal options for additional five-year terms. In addition to our principal executive office, we lease or own hospital locations as noted in the table below. All of our hospital leases, which represent the substantial majority of our rent expense, have at least five years remaining on their terms after taking into consideration renewal options, except for a lease that terminates in late 2029. Our consolidated entities associated with our leased hospitals are generally responsible for property taxes, property and casualty insurance, and routine maintenance expenses. We do not believe any one of our individual properties is material to our consolidated operations.

The following table sets forth information regarding our hospital locations as of December 31, 2025:

The rest of Item 2

Number of Hospitals

State · Licensed Beds · Building and Land Owned · Building Owned and Land Leased · Building and Land Leased · Total

Alabama* · 467 · 3 · 3 · 1 · 7

Arizona · 406 · 1 · 2 · 3 · 6

Arkansas · 381 · 3 · 1 · 1 · 5

California · 251 · 4 · — · — · 4

Colorado · 124 · 1 · — · 1 · 2

Connecticut* · 40 · 1 · — · — · 1

Delaware* · 50 · — · 1 · — · 1

Florida · 1,718 · 22 · 3 · — · 25

Georgia* · 410 · 6 · (1) · 1 · 1 · 8

Idaho · 40 · — · 1 · — · 1

Illinois* · 205 · 2 · 2 · — · 4

Indiana · 98 · 1 · — · — · 1

Iowa* · 40 · 1 · — · — · 1

Kansas · 177 · 1 · — · 1 · 2

Kentucky* · 309 · 3 · 1 · — · 4

Louisiana · 87 · 2 · — · — · 2

Maine* · 100 · — · — · 1 · 1

Maryland* · 144 · 2 · — · — · 2

Massachusetts* · 546 · 2 · — · 2 · 4

Mississippi* · 55 · — · — · 1 · 1

Missouri* · 236 · — · 2 · — · 2

Nevada · 219 · 2 · — · 1 · 3

New Hampshire · 50 · — · 1 · — · 1

New Jersey* · 199 · 1 · 1 · 1 · 3

New Mexico · 87 · 1 · — · — · 1

North Carolina* · 68 · 1 · — · — · 1

North Dakota · 40 · — · — · 1 · 1

Ohio · 200 · 2 · 1 · 1 · 4

Oklahoma · 100 · 1 · 1 · — · 2

Pennsylvania · 661 · 5 · — · 4 · 9

Puerto Rico* · 77 · — · — · 2 · 2

Rhode Island* · 50 · 1 · — · — · 1

South Carolina · 505 · 4 · 4 · 1 · 9

South Dakota · 40 · 1 · — · — · 1

Tennessee* · 574 · 7 · 3 · — · 10

Texas · 1,992 · 16 · 3 · 10 · 29

Utah · 84 · 1 · — · — · 1

Virginia* · 307 · 2 · 1 · 3 · 6

West Virginia* · 272 · 2 · 2 · — · 4

Wisconsin · 56 · 1 · — · — · 1

11,465 · 103 · 34 · 36 · 173

* Hospital certificate of need state or U.S. territory.

(1) The inpatient rehabilitation hospital in Augusta, Georgia is party to an industrial development bond financing that reduces the ad valorem taxes payable by the hospital. In connection with this bond structure, title to the related property is held by the local development authority. We lease the related hospital property and hold the bonds issued by that authority, the payment on which equals the amount payable under the lease. We may terminate the bond financing and the associated lease at any time at our option without penalty, and fee title to the hospital property will return to us.

Our principal executive office, hospitals, and other properties are suitable for their respective uses and are, in all material respects, adequate for our present needs. Information regarding the utilization of our licensed beds and other operating statistics can be found in Item 7, Management’s Discussion and Analysis of Financial Condition and Results of Operations.

Item 2 of the 10-K filed Feb 26, 2026.17

The story

Founded by Richard M. Scrushy in 1984.1

Early years

Encompass Health was incorporated as Amcare, Inc. on February 22, 1984 in Birmingham, Alabama by Richard M. Scrushy and four co-founders as a provider of outpatient rehabilitation services. Scrushy developed the idea for the company in 1983 while working at Lifemark Corporation, a publicly traded hospital company that was in the process of being acquired by a competitor. Scrushy, a Lifemark vice president, recognized the need for physical therapy services were increasing at the same time hospitals were looking to cut costs and that it would be more cost-effective to offer those services in an outpatient setting.

Scrushy and the four co-founders invested $50,000 to start the company, with Scrushy contributing the largest amount at $25,000, and Citicorp Venture Capital providing an additional $1 million in funding. Scrushy took on the role of chairman and CEO, which he would hold until 2003, while the four co-founders took on administrative roles. The company opened its first outpatient facility in Little Rock, Arkansas in early 1984 followed by a second facility in Birmingham later that year.

The company changed its name to HealthSouth Rehabilitation Corporation in 1985 to distinguish itself from other healthcare companies in the market and purchased its first inpatient rehabilitation hospital in early 1986. This was followed by an initial public offering (IPO) on the Nasdaq later that year in August. At the end of Scrushy's speech at the last investor roadshow presentation in New York City before HealthSouth's IPO, the traditionally stoic investment bankers gave Scrushy a standing ovation. One banker in attendance told Aaron Beam, co-founder and then CFO, that he had never seen a reaction like that before and attributed it to Scrushy's remarkable ability to sell the concept behind HealthSouth.

The company moved its listing to the New York Stock Exchange in 1989 and purchased the 219-bed South Highlands Hospital on Birmingham's Southside. The purchase was significant for the company as it marked HealthSouth's entrance into acute care hospitals that focused on orthopedics and launched HealthSouth as a recognizable name in sports medicine. South Highlands Hospital, which was renamed HealthSouth Medical Center, was affiliated with the Alabama Sports Medicine and Orthopaedic Center and its world-renowned orthopedic surgeons Dr. James Andrews and Dr. Larry Lemak, as well as the American Sports Medicine Institute. The success of this venture led HealthSouth to later develop partnerships with many of the nation's other top orthopedic surgeons and clinics, including Dr. Frank Jobe at Kerlan-Jobe Orthopaedic Clinic in Los Angeles, California.

Growth

The company grew steadily during its first few years by opening new facilities and making small acquisitions. It had 50 facilities across the United States by 1990 and $400 million in annual revenue by 1992. The company made its first large acquisition in late 1993 when it acquired 28 inpatient rehabilitation hospitals and 45 outpatient rehabilitation facilities from National Medical Enterprise. The acquisition double the size of the company and made HealthSouth the nation's largest provider of inpatient and outpatient rehabilitation. HealthSouth grew its inpatient business further when it acquired ReLife the following year.

HealthSouth expanded rapidly through acquisitions during the mid-to-late 1990s and changed its name again, dropping "Rehabilitation" in 1994, becoming HealthSouth Corporation. That same year it entered the diagnostic imaging business with the purchase of Diagnostic Health Corporation. HealthSouth entered the ambulatory surgery center business in early 1995 with the purchase of Surgical Health Corporation. One month later the company announced the purchase of NovaCare's rehabilitation hospital business. After additional surgery center acquisitions during 1995, including the $1.2 billion acquisition of Surgical Care Affiliates, HealthSouth became the nation's largest provider of outpatient surgery. HealthSouth rounded out the year by purchasing Caremark Orthopedic Services from Caremark International and announcing the acquisition of Advantage Health Corp. ReadiCare and Health Images were acquired in 1996 to strengthen HealthSouth's occupational health and diagnostic imaging businesses, respectively.

The company's largest acquisition during the 1990s came in February 1997 when HealthSouth announced it would acquire Horizon/CMS Healthcare Corp for $1.8 billion. Horizon/CMS was a large publicly traded healthcare company that primarily focused on outpatient rehabilitation, inpatient rehabilitation hospitals, and long-term care hospitals. A few months after the acquisition closed, HealthSouth sold Horizon/CMS's long-term care assets to Integrated Health Services for $1.15 billion in cash. HealthSouth continued to grow its surgery center division by acquiring ASC Network Corp. in late 1997 and National Surgery Centers along with 34 surgery centers from Columbia/HCA during the summer of 1998.

By 1999, the company, along with most healthcare providers, began experiencing a decline in earnings following the passage of the Balanced Budget Act of 1997. That summer, HealthSouth announced it would split into two separate companies. HealthSouth Corporation would continue to own and operate the outpatient rehabilitation, surgery center, diagnostic imagining, and occupational health businesses while HealthSouth Hospital Corporation would own and operate the inpatient rehabilitation hospitals and the company's four acute care hospitals. The plan was shelved several months later when the company revised its earnings estimates.

Read the full text

HealthSouth had over 2,000 facilities across all 50 states by the end of 1999 and was one of the nation's largest providers of healthcare services. It also had expanded into international markets through its many acquisitions, with facilities in the United Kingdom, Australia, Puerto Rico, Canada, and later Saudi Arabia. The company's dominance as the largest provider in all its lines of business benefited HealthSouth when it came to negotiations with health insurance providers.

Growth through acquisitions slowed by the end of the 1990s as the company had acquired many of its competitors. The company announced the sale of its occupational health business to U.S. HealthWorks in May 2001. Later that year, the company announced it was partnering with Oracle Corporation to build the world's first all-digital acute care hospital. The 13-story structure, known informally as the "Digital Hospital", would be built in Birmingham on 19-acres of land adjacent to HealthSouth's corporate headquarters and serve as a replacement for its Southside medical center. Construction was halted two years later following an accounting scandal at the company.

Accounting scandal

Following large sales of company stock by Scrushy in May and July 2002, and a surprise announcement of an annual $175 million shortfall in earnings during second quarter's earnings release in August, the U.S. Securities and Exchange Commission launched an investigation into Scrushy and HealthSouth to determine what was known about the shortfall before the sales. On March 19, 2003, the SEC took action against the company regarding fraudulent accounting. Scrushy and other high-ranking executives were accused of directing company employees to report false earnings in order to meet Wall Street's expectations.

The fraud was revealed when two executive officers, fearful the fraud would soon be exposed and of new laws enacted by Sarbanes-Oxley, went to the FBI separately to admit their involvement. SEC investigators had not suspected fraud in their initial investigation. It was later revealed the $175 million earnings shortfall announcement was a cover to unwind a significant portion of the fraud. On November 4, 2003, Scrushy was indicted in the accounting fraud. HealthSouth cooperated with the government in its investigation and was not indicted.

The board of directors acted quickly after the fraud was revealed. The entire executive management team, including Scrushy, was fired or replaced, with directors Joel Gordon and Robert P. May stepping in as interim chairman and interim CEO, respectively. HealthSouth was delisted from the New York Stock Exchange and removed from the S&P 500. The restructuring firm Alvarez & Marsal was brought in, at the advice of JPMorgan Chase, to assist with financial restatements and to work with HealthSouth's lenders. Although there were concerns following the fraud announcement that the company could file for bankruptcy protection, this turned out to be unfounded, and several months later the company announced it had worked out financing agreements with lenders and that all lines of business were producing sufficient cash flow. It was later determined that $2.7 billion in fraud had occurred from 1996 to 2003.

Repositioning the company

From 2003 until 2006, the company worked to address operational inefficiencies and correct actions that led to fraud. Jay Grinney, president of HCA's Eastern division, was brought in as HealthSouth's new president and CEO in 2004. U.S. Can Corporation executive John Workman was brought in to serve as the company's CFO, and Mike Snow, president of HCA's Gulf Coast division, joined as COO. The company sold or closed underperforming facilities and disposed of corporate waste accrued under Scrushy, including most of the company's fleet of corporate jets.

The company sold its Southside medical center in Birmingham to UAB in early 2006, marking the end of its venture into orthopedic-focused acute care hospitals. The company had previously sold HealthSouth Doctors' Hospital in Coral Gables, Florida to Baptist Health South Florida in late 2003 and closed HealthSouth Metro West Hospital in west Birmingham in late 2005. HealthSouth's medical center in Dallas, Texas was converted to an inpatient rehabilitation hospital in 2005.

On May 15, 2006, the company became current with SEC regulations when it filed its first 10-Q since third quarter 2002. The company unveiled a restructuring plan in August which involved selling, spinning-off or other disposition of its surgery, outpatient, and diagnostic divisions, along with a 1-for-5 reverse stock split to coincide with its relisting on the New York Stock Exchange. The sales would allow the company to focus on growing its inpatient rehabilitation hospital division. The last step in the company's recovery from the accounting scandal occurred in October when HealthSouth was relisted on the New York Stock Exchange.

HealthSouth announced it was selling its outpatient business to Select Medical Corporation in January 2007. Two months later it announced the sale of its surgery center division to private equity firm TPG Capital, retaining a small equity interest in the newly formed company. In April, HealthSouth announced a definitive agreement to sell its diagnostic division to private equity firm The Gores Group. The outpatient business transaction was completed in May. The surgery center and diagnostic imaging transactions

closed in June and July with the re-creations of Surgical Care Affiliates and Diagnostic Health Corporation.

In March 2008, HealthSouth closed on the sale of its corporate headquarters campus and "Digital Hospital" in Birmingham to Daniel Corporation, a commercial real estate firm. The deal included the 85-acre corporate headquarters property and the adjacent 19-acre parcel of land containing the incomplete 13-story "Digital Hospital". HealthSouth retained a 40% residual interest in the hospital property and leased back the headquarters' building. The incomplete hospital was eventually sold to Community Health Systems and today is known as Grandview Medical Center.

From Wikipedia’s article on Encompass Health, shared under CC BY-SA 4.0.7

Leadership

Who has led Encompass Health, and when. Pick a name to see everywhere that person has worked.

Board members and other officers (33)

Products and brands

  • physical medicine and rehabilitation

Listed on Wikidata.1

Subsidiaries and ownership

Subsidiaries

  • HealthSouth Rehabilitation Hospital of Tinton Falls

Subsidiaries (Exhibit 21)

  • HCS Limited Cayman Islands, BWI8

From Wikidata.1 The subsidiaries the company lists in Exhibit 21 of its annual report, as filed.

Former names

  • HEALTHSOUTH CORPMar 8, 1995 to Dec 12, 20176
  • HEALTHSOUTH REHABILITATION CORPFeb 10, 1994 to Jun 22, 19946

Timeline

  1. Aug 13, 20268-K Other events64
  2. Aug 5, 20268-K Results of operations; Regulation FD disclosure65
  3. Jun 1, 20268-K Entered a material agreement; New debt or obligation66
  4. May 15, 20268-K Entered a material agreement; Other events67
  5. May 11, 20268-K Shareholder vote68
  6. Apr 30, 20268-K Results of operations; Regulation FD disclosure69
  7. Mar 10, 20268-K Entered a material agreement; Ended a material agreement; New debt or obligation70
  8. Feb 20, 20268-K Executive or director change71
  9. Feb 5, 20268-K Results of operations; Regulation FD disclosure72
  10. Feb 2, 20268-K Executive or director change73
  11. Dec 1, 20258-K Regulation FD disclosure74
  12. Oct 29, 20258-K Results of operations; Regulation FD disclosure75
  13. Jan 5, 2022New chief executive Barbara Ann Jacobsmeyer becomes CEO18
  14. Jan 5, 2017New chief executive Mark J. Tarr becomes CEO19
  15. Jan 6, 2015New chief executive April Kaye Bullock Anthony becomes CEO20
  16. Feb 24, 2006New chief executive Jay Grinney becomes CEO21
  17. 1984Founded Founded1

Calendar

Coming up

  1. Oct 28, 2026 · After the closeReports results for the quarter ending Sep/2026 A year earlier it reported $1.23 a share, on Oct 29, 2025.76

When it reported results

  1. Aug 5, 2026Reported quarterly or annual results65
  2. Apr 30, 2026Reported quarterly or annual results69
  3. Feb 5, 2026Reported quarterly or annual results72
  4. Oct 29, 2025Reported quarterly or annual results75
  5. Aug 4, 2025Reported quarterly or annual results77
  6. Apr 24, 2025Reported quarterly or annual results78
  7. Feb 6, 2025Reported quarterly or annual results79
  8. Oct 28, 2024Reported quarterly or annual results80

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

582 filings to the SEC since October 2021: 5 annual reports, 15 quarterly reports, 64 major events, 441 insider forms, 23 large holders, 34 other. The latest 20:

  1. Sep 1, 20264 EDGAR
  2. Sep 1, 20264 EDGAR
  3. Aug 31, 2026144 EDGAR
  4. Aug 19, 2026S-3ASR EDGAR
  5. Aug 14, 2026SCHEDULE 13G EDGAR
  6. Aug 13, 20268-K EDGAR
  7. Aug 11, 20264 EDGAR
  8. Aug 11, 20264 EDGAR
  9. Aug 11, 20264 EDGAR
  10. Aug 10, 2026144 EDGAR
  11. Aug 10, 2026144 EDGAR
  12. Aug 10, 2026144 EDGAR
  13. Aug 7, 202610-Q EDGAR
  14. Aug 5, 20268-K EDGAR
  15. Jul 31, 2026SCHEDULE 13G/A EDGAR
  16. Jul 16, 20264 PRIMARY DOCUMENT EDGAR
  17. Jul 16, 20264 PRIMARY DOCUMENT EDGAR
  18. Jul 16, 20264 PRIMARY DOCUMENT EDGAR
  19. Jul 16, 20264 PRIMARY DOCUMENT EDGAR
  20. Jul 16, 20264 PRIMARY DOCUMENT EDGAR

The 582 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

29 open-market trades by officers, directors and large owners since October 2021: 4 buys and 25 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Aug 31, 2026Price Andrew LChief Accounting OfficerSale5,211$120.93$630.2KForm 4
Aug 31, 2026Darby John PatrickEVP, Gen Counsel & SecretarySale4,858$121.09$588.3KForm 4
Aug 10, 2026COLTHARP DOUGLAS EEVP & Chief Financial OfficerSale18,869$125.38$2.4MForm 4
Aug 10, 2026Tarr Mark JPresident & CEOSale173,148$125.47$21.7MForm 4
Aug 10, 2026Darby John PatrickEVP, Gen Counsel & SecretarySale8,906$125.95$1.1MForm 4
May 15, 2026COLTHARP DOUGLAS EEVP & Chief Financial OfficerSale27,694$106.83$3.0MForm 4
May 11, 2026Tuer Patrick WilliamEVP, Chief Operating OfficerSale682$104.56$71.3KForm 4
Mar 9, 2026Fay EdmundSr. Vice Pres. and TreasurerSale11,937$107.00$1.3MForm 4
Feb 11, 2026Tarr Mark JPresident & CEOSale150,000$111.64$16.7MForm 4
Feb 10, 2026Tuer Patrick WilliamEVP, Chief Operating OfficerSale2,804$107.62$301.8KForm 4
Aug 27, 2025Tuer Patrick WilliamEVP, Chief Operating OfficerSale1,020$123.59$126.1KForm 4
May 20, 2025Tarr Mark JPresident & CEOSale118,384$121.53$14.4MForm 4
May 6, 2025Charbonneau Elissa JoyChief Medical OfficerSale4,279$116.61$499.0KForm 4
Apr 29, 2025Darby John PatrickEVP, Gen Counsel & SecretarySale10,000$114.79$1.1MForm 4
Apr 29, 2025COLTHARP DOUGLAS EEVP & Chief Financial OfficerSale43,575$115.15$5.0MForm 4
Feb 13, 2025Price Andrew LChief Accounting OfficerSale5,042$98.29$495.6KForm 4
Aug 13, 2024COLTHARP DOUGLAS EEVP & Chief Financial OfficerSale12,260$86.34$1.1MForm 4
May 24, 2024Charbonneau Elissa JoyChief Medical OfficerSale10,000$85.02$850.2KForm 4
May 6, 2024Darby John PatrickEVP, Gen Counsel & SecretarySale14,543$83.94$1.2MForm 4
May 3, 2024CARMICHAEL GREG DDirectorBuy2,000$83.73$167.5KForm 4

All 29 trades can be filtered by person here when JavaScript is on.

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Executive pay

What the company paid its top executives, from the summary compensation table in its proxy statement. Total pay includes salary, bonus, stock and option awards and other pay, as the company valued them.

YearExecutiveAgeSalaryTotal pay
2025Mark J. Tarr64$1.1M$10.3M89
2025Douglas E. Coltharp64$750.0K$4.5M89
2025Patrick W. Tuer42$550.0K$2.8M89
2025Patrick Darby61$625.0K$2.7M89
2025Elissa J. Charbonneau66$435.0K$1.4M89
2024President and Chief Executive Officer$1.1M$9.3M89
2024Executive VicePresident and Chief Financial Officer$700.0K$3.9M89
2024Executive Vice PresidentGeneral Counsel and Secretary$625.0K$2.6M89
2024Chief Medical Officer$415.0K$1.3M89
2023President and Chief Executive Officer$1.1M$8.8M89
2023Executive VicePresident and Chief Financial Officer$700.0K$5.8M89
2023Executive Vice PresidentGeneral Counsel and Secretary$550.0K$3.2M89
2023Chief Medical Officer$415.0K$1.3M89

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 100. Change is in shares since the quarter before.

FundSharesValueShare of the fundChange
BlackRock, Inc.10,484,385$1.1B0.0%−284,328
Vanguard Portfolio Management LLC4,924,664$497.8M0.0%−34,881
Vanguard Capital Management LLC4,475,896$452.4M0.0%+9,659
Wellington Management Group Llp3,278,739$331.4M0.1%−570,116
State Street Corp3,185,798$322.0M0.0%+40,824
Citadel Advisors LLC2,563,104$259.1M0.2%+2,051,217
Fuller & Thaler Asset Management, Inc.2,460,657$248.7M0.7%+230,678
Alliancebernstein L.P.2,471,751$239.1M0.1%−149,494
Two Sigma Investments, LP2,267,668$229.2M0.2%+45,567
Geode Capital Management, LLC1,890,743$191.2M0.0%−7,924
Dimensional Fund Advisors LP1,743,028$176.2M0.0%+68,244
Goldman Sachs Group Inc1,550,797$156.8M0.0%−254,924
Invesco Ltd.1,161,108$117.4M0.0%−2,224,997
Arrowstreet Capital, Limited Partnership1,156,930$116.9M0.1%−25,644
Norges Bank1,154,864$116.7M0.0%New
William Blair Investment Management, LLC1,151,085$116.4M0.3%+347,934
Morgan Stanley1,146,873$115.9M0.0%+249,891
Jpmorgan Chase & Co1,133,561$114.8M0.0%−97,910
Raymond James Financial Inc1,064,233$107.6M0.0%−2,773
American Century Companies Inc1,050,470$106.2M0.0%+298,417
Eversept Partners, LP1,026,919$103.8M5.7%+832,815
Brown Advisory Inc1,012,731$102.4M0.2%+319,582
Holocene Advisors, LP977,634$98.8M0.2%+827,311
Northern Trust Corp970,684$98.1M0.0%+12,486
Sumitomo Mitsui Trust Group, Inc.930,330$94.0M0.1%+982

13F reports cover disclosed long positions in U.S. stocks only.

Members of Congress who traded it

6 trades disclosed by members of Congress. “Vs S&P since” is the stock’s change since the trade minus the S&P 500’s.

DateMemberTradeAmountVs S&P sinceFiling
Oct 31, 2025Lisa C. McClainRepublican, HouseSale$1,001 - $15,000+0.8%Report
Oct 30, 2025Lisa C. McClainRepublican, HouseBuy$1,001 - $15,000−4.1%Report
Oct 30, 2025Lisa C. McClainRepublican, HouseSale$1,001 - $15,000+4.1%Report
Jul 22, 2025Lisa C. McClainRepublican, HouseBuy$1,001 - $15,000−4.8%Report
Aug 27, 2020Susie LeeDemocratic, HouseSale$1,001 - $15,000−25.2%Report
May 19, 2020Susie LeeDemocratic, HouseBuy$1,001 - $15,000−41.5%Report

Members report amounts as ranges, not exact figures. Returns are price-only (no dividends).

SEC filer profile

How Encompass Health is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGAREncompass Health Corp2
  • CIK0000785161
  • Employer ID (EIN)63-086040717
  • Filer statusLarge accelerated filer not an emerging growth company; not a smaller reporting company; not a shell company17
  • Incorporated inDelaware17
  • Fiscal year endsDecember 312
  • Industry code (SIC)8060 Services-Hospitals2
  • SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance2
  • Business address9001 Liberty Parkway, Birmingham, AL 352422
  • Phone205-967-71162
  • Shares outstanding98,653,384 as of Jul 28, 202616
  • Public float$12.2B as of Jun 30, 202517
  • AuditorPricewaterhouseCoopers LLP, Birmingham, Alabama PCAOB ID 238; it also attests to the company’s internal control over financial reporting17
  • On EDGAR sinceFeb 10, 19942
  • Filings2,833 in all: 4 (1,573), 8-K (536), SC 13G/A (110), 10-Q (86), 3 (43), 424B3 (43), SC 13G (42), DEF 14A (32)2
    All 63 form types

    10-K (31), 8-K/A (29), 4/A (27), S-8 (27), 424B5 (20), 144 (18), S-4 (18), UPLOAD (18), CORRESP (15), FWP (12), ARS (11), S-4/A (11), NT 10-Q (10), S-3ASR (9), POSASR (8), PRE 14A (7), 10-K/A (6), NO ACT (6), SC 13D (6), 10-Q/A (5), DEFA14A (5), S-3 (5), 424B2 (4), 424B7 (4), EFFECT (4), NT 10-K (4), SCHEDULE 13G/A (4), S-11/A (3), S-3/A (3), S-8 POS (3), SC TO-I/A (3), SCHEDULE 13G (3), 15-12G (2), 424B1 (2), 424B4 (2), 5 (2), 8-A12B (2), CERTNYS (2), 15-12B (1), 25-NSE (1), 3/A (1), 424A (1), CT ORDER (1), DEFR14A (1), NTN 10Q (1), POS AM (1), PRER14A (1), PRES14A (1), PX14A6G (1), REGDEX (1), RW (1), S-11 (1), S-3MEF (1), SC 13D/A (1), SC TO-I (1)

  • Latest filingsAnnual report (10-K) Feb 26, 2026
    Quarterly report (10-Q) Aug 7, 2026
    Proxy statement (DEF 14A) Apr 7, 2026
    Latest 8-K (8-K) Aug 13, 2026

Securities registered for trading

ClassSymbolExchange
Common Stock, $0.01 par valueEHCNew York Stock Exchange

From the cover page of the 10-K filed Feb 26, 2026 (Section 12(b) of the Exchange Act).17

Risk factors and legal proceedings

The risks Encompass Health names in Item 1A of its 10-K filed Feb 26, 2026: 31 risks under these headings, as written.17

  • Reimbursement Risks
  • Reductions or changes in reimbursement from government or third-party payors could adversely affect our Net operating revenues and other operating results.
  • Reimbursement claims are subject to various audits from time to time and such audits may negatively affect our operations and our cash flows from operations.
  • Substantive and procedural deficiencies in the administrative appeals process associated with denied Medicare reimbursement claims could delay and reduce our reimbursement for services previously provided.
  • Changes in our payor mix or the acuity of our patients could adversely affect our Net operating revenues or our profitability.
  • Delays in collection or non-collection of our accounts receivable could adversely affect our business, financial position, results of operations, cash flows, and liquidity.
  • Efforts to reduce payments to healthcare providers undertaken by third-party payors, conveners, and referral sources could adversely affect our revenues and profitability.
  • Quality reporting requirements could adversely affect the Medicare reimbursement we receive.
  • Other Regulatory Risks
  • The ongoing evolution of the healthcare delivery system, including alternative payment models and value-based purchasing initiatives, in the United States may significantly affect our business and results of operations.
  • Other legislative and regulatory initiatives and changes affecting the industry could adversely affect our business and results of operations.
  • Compliance with the extensive laws and government regulations applicable to healthcare providers requires substantial time, effort and expense, and if we fail to comply with them, we could suffer penalties or be required to make significant changes to our operations.
The other 21 risks
  • The use of sub-regulatory guidance, statistical sampling, and extrapolation by CMS, Medicare contractors, HHS-OIG, and DOJ to deny claims, expand enforcement claims, and advocate for changes in reimbursement policy increases the risk that we could experience reduced revenue, suffer penalties, or be required to make significant changes to our operations.
  • Efforts to comply with regulatory mandates to increase the use of electronic health data and health system interoperability may lead to enforcement and negative publicity which could adversely affect our business.
  • If any of our hospitals fail to comply with the Medicare enrollment requirements or conditions of participation, that hospital could be terminated from the Medicare program.
  • If we are found to have violated applicable privacy and information security laws and regulations or our contractual obligations, we could be subject to sanctions, fines, damages and other civil or criminal penalties, which could increase our liabilities, harm our reputation and have a material adverse effect on our business, financial position, results of operation and liquidity.
  • We are subject to federal, state and local laws and regulations that govern our employment practices, including minimum wage, overtime, living wage and paid-time-off requirements. Failure to comply with these laws and regulations, or changes to these laws and regulations that increase our employment-related expenses, could adversely impact our operations.
  • The pricing transparency and similar consumer protection rules could adversely affect our business and results of operations.
  • Other Operational Risks
  • The proper function, availability, and security of our information systems are critical to our business and failure to maintain proper function, availability, or security of our information systems or protect our data against unauthorized access could have a material adverse effect on our business, financial position, results of operations, and cash flows.
  • The failure of our business partners and vendors to maintain the proper function, availability, or security of their information systems or to protect against unauthorized access could have a material adverse effect on our business, financial position, results of operations, and cash flows.
  • We face intense competition for patients from other healthcare providers.
  • If we are unable to provide a consistently high quality of care, our business will be adversely impacted.
  • If we are unable to maintain or develop relationships with patient referral sources, our growth and profitability could be adversely affected.
  • We may have difficulty completing joint ventures, investments and transactions that increase our capacity consistent with our growth strategy.
  • Acute-care hospitals that participate in joint ventures with us may experience operational or financial challenges that, in turn, affect our joint venture inpatient rehabilitation hospitals.
  • We may make investments or complete transactions that could expose us to unforeseen risks and liabilities.
  • We may not be able to successfully integrate acquisitions or realize the anticipated benefits of any acquisitions.
  • Competition for staffing, shortages of qualified personnel, union activity or other factors may increase our staffing costs and reduce profitability.
  • We are a defendant in various lawsuits, and may be subject to liability under qui tam cases, the outcome of which could have a material adverse effect on us.
  • We may be more vulnerable to the effects of a public health emergency than other businesses due to the nature of our patients, and a regional or global socio-political, weather or other catastrophic event could severely disrupt our business.
  • Regulatory and other efforts to promote a transition to a lower-carbon economy may result in significant operational and financial challenges for us.
  • Financial Risks
  • We may incur additional indebtedness in the future, and that debt or the associated increased leverage may have negative consequences for our business. The restrictive covenants included in the terms of our indebtedness could affect our ability to execute aspects of our business plan successfully.
  • Uncertainty in the credit markets could adversely affect our financial condition or our growth opportunities.

Legal proceedings

We provide services in the highly regulated healthcare industry. Furthermore, operating inpatient rehabilitation hospitals requires significant staffing and involves intensive therapy for individuals suffering from significant physical or cognitive disabilities or injuries. In the ordinary course of our business, we are subject to regulatory and other governmental audits and investigations and are party to various legal actions, proceedings, and claims, including wage and hour, employment and personal injury claims, some of which seek to be certified as class or collective actions. These matters could potentially subject us to sanctions, damages, recoupments, fines, and other penalties. Some of these matters have been material to us in the past, and others in the future may, either individually or in the aggregate, be material and adverse to our business, financial position, results of operations, and liquidity.

Additionally, the False Claims Act (the “FCA”) allows private citizens, called “relators,” to institute civil proceedings on behalf of the United States alleging violations of the FCA. These lawsuits, also known as “qui tam” actions, are common in the healthcare industry and can involve significant monetary damages, fines, attorneys’ fees and the award of bounties to the relators who successfully prosecute or bring these suits to the government. It is possible that qui tam lawsuits have been filed against us, which suits remain under seal, or that we are unaware of such filings or precluded by existing law or court order from discussing or disclosing the filing of such suits. Therefore, from time to time, we may be party to one or more undisclosed qui tam cases brought pursuant to the FCA.

Information relating to certain legal proceedings in which we are involved is included in Note 16, Contingencies and Other Commitments, to the accompanying consolidated financial statements.

The opening of Item 3, Legal Proceedings.17

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
    Company websiteEncompass Health logo
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49
  50. 50
  51. 51
  52. 52
  53. 53
  54. 54
  55. 55
  56. 56
  57. 57
  58. 58
  59. 59
  60. 60
  61. 61
  62. 62
  63. 63
  64. 64
    SEC EDGAROther events
  65. 65
  66. 66
  67. 67
  68. 68
  69. 69
  70. 70
  71. 71
  72. 72
  73. 73
  74. 74
  75. 75
  76. 76
  77. 77
  78. 78
  79. 79
  80. 80
  81. 81
  82. 82
  83. 83
  84. 84
  85. 85
  86. 86
  87. 87
  88. 88
  89. 89